The active ingredient available in a pharma drug for animals is termed as veterinary APIs. According to the Persistence Market Research, among the varied veterinary active pharmaceutical ingredient (APIs) manufacturers, antiparasitic veterinary API segment was expected to reach US$ 4,600 million by 2025, followed by anti-infectives for animals.

Only when the veterinary API is of high quality, the pharma drug supplied for the animal care would remain safe and effective. These quality based APIs must have a certified Drug Establishment Licence and they should be manufactured as per the Good Manufacturing Practices.

Considering the market growth of varied API segments in addition to the quality level, our drugdu (Ddu) team has collaborated with the veterinary active pharmaceutical ingredient (APIs) manufacturer named 'Zhengzhou RongRuiXiang Animal Pharmaceutical Co., Ltd, for the supply of qualitative veterinary APIs.

'Zhengzhou RongRuiXiang Animal Pharmaceutical Co., Ltd

This company was established in the year 2008, having nearly ten years of experience to date. In the year 2017, they started to export and import section to expand well in the market. They developed a bird flu subunit, in collaboration with Henan University of Science and Technology. Same way, after joining hands with the veterinary medicine research center of Nanjing agricultural university, they developed an antibiosis and antiviral drug unit.